Table 2.

Circulating lipids (mmol/L) according to the subgroups of patients.

	HR−			HR+
	Ki-67 ≤ 20% (Prolif−) (n = 19)	Ki-67 ≥ 30% (Prolif+) (n = 29)	p	Ki-67 ≤ 20% (Prolif−) (n = 51)	Ki-67 ≥ 30% (Prolif+) (n = 41)	p
Plasma Cholesterol	5.30 [4.53–5.93]	5.25 [4.07–5.75]	0.77	5.03 [4.17–5.83]	5.36 [4.44–5.91]	0.30
Plasma Triglycerides	1.23 [0.91–1.74]	1.11 [0.79–1.37]	0.38	0.90 [0.71–125]	0.92 [0.74–1.12]	0.83
HDL Cholesterol	1.48 [1.10–1.66]	1.39 [1.07–1.51]	0.14	1.30 [1.09–1.62]	1.38 [1.14–1.57]	0.30
Non-HDL Cholesterol	3.90 [3.19–4.65]	3.79 [2.82–4.46]	0.77	3.57 [2.94–4.39]	3.84 [3.17–4.50]	0.53

Expressed as median mmol/L (25th–75th). p value ≤ 0.05, significant difference between the two groups, Wilcoxon test. HDL: high-density lipoprotein.